ANALYSIS OF INTRAHEPATIC CYTOKINE EXPRESSION OF CHRONIC HCV-INFECTED PATIENTS ACCORDING TO RESPONSE TO INTERFERON THERAPY

被引：0
作者：
GAWECO, AS
VANTHIEL, DH
RUSTGI, V
OTTO, HF
SCHNEIDER, F
HOFMANN, WJ
机构：
[1] UNIV HEIDELBERG, INST PATHOL, W-6900 HEIDELBERG, GERMANY
[2] OKLAHOMA TRANSPLANTAT INST, OKLAHOMA CITY, OK USA
[3] INOVA INST, FALLS CHURCH, VA USA
来源：
GASTROENTEROLOGY | 1995年 / 108卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1070 / A1070
页数：1
相关论文
共 50 条
  • [41] KINETICS OF HCV-VIREMIA IN INTERFERON-ALPHA-TREATED AND UNTREATED HCV-INFECTED HEMODIALYSIS-PATIENTS
    UMLAUF, F
    WEISS, G
    URBANEK, M
    HAUN, M
    WEYRER, K
    KOENIG, P
    VOGEL, W
    GRUNEWALD, K
    HEPATOLOGY, 1994, 20 (04) : A166 - A166
  • [42] Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patients (vol 23, pg 149, 2018)
    Lucejko, Mariusz
    Flisiak, Robert
    ANTIVIRAL THERAPY, 2018, 23 (04) : 383 - 383
  • [43] Expression of natural cytotoxic receptors by NK cells from HCV-infected patients
    Conesa, Angela
    Millet, Carmen
    Blanca, Isaac
    Machado, Irma
    Leon, LeonRoberto
    Marquez, Maria
    Toro, Felix
    CLINICAL IMMUNOLOGY, 2008, 127 : S134 - S135
  • [44] HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
    Canini, Laetitia
    Imamura, Michio
    Kawakami, Yoshiiku
    Uprichard, Susan L.
    Cotler, Scott J.
    Dahari, Harel
    Chayama, Kazuaki
    PLOS ONE, 2017, 12 (12):
  • [45] Intrahepatic Landscape of Regulatory T-Cell Subsets in Chronically HCV-Infected Patients With Cirrhosis and HCC
    Wang, Xiao-Fan
    Korangy, Firouzeh
    HEPATOLOGY, 2014, 60 (05) : 1461 - 1462
  • [46] Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes
    Kevans, D.
    Farrell, G.
    Hopkins, S.
    Mahmud, N.
    White, B.
    Norris, S.
    Bergin, C.
    HAEMOPHILIA, 2007, 13 (05) : 593 - 598
  • [47] Excellent efficacy but increased rate of severe adverse events in HCV-infected elderly patients undergoing interferon-free therapy
    Lens, S.
    Fernandez, I.
    Rodriguez-Tajes, S.
    Vergara, M.
    Forne, M.
    Calleja, J. L.
    Diago, M.
    Llaneras, J.
    Llerena, S.
    Torras, X.
    Sacristan, B.
    Roget, M.
    Fernandez-Rodriguez, C. M.
    Navascues, C.
    Fuentes, J.
    Sanchez-Ruano, J. J.
    Simon, M. A.
    Saez-Royuela, F.
    Baliellas, C.
    Morillas, R. M.
    Forns, X.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S735 - S735
  • [48] Visual and brainstem auditory evoked potentials in HCV-infected patients before and after interferon-free therapy - A pilot study
    Waliszewska-Prosol, Marta
    Bladowska, Joanna
    Ejma, Maria
    Fleischer-Stepniewska, Katarzyna
    Rymer, Weronika
    Sasiadek, Marek
    Pawlowski, Tomasz
    Malyszczak, Krzysztof
    Inglot, Malgorzata
    Zelwetro, Agnieszka
    Podgorski, Przemyslaw
    Knysz, Brygida
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 80 : 122 - 128
  • [49] Epigenetic analysis of the IFN3 gene identifies a novel marker for response to therapy in HCV-infected subjects
    Waring, J. F.
    Davis, J. W.
    Dumas, E.
    Cohen, D.
    Idler, K.
    Abel, S.
    Georgantas, R.
    Podsadecki, T.
    Dutta, S.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (05) : 397 - 403
  • [50] Broadly reactive antibodies to hypervariable region 1 in HCV-infected patients: Relation to viral loads, response to interferon and heterogeneity.
    Yoshioka, K
    Hattori, M
    Terasawa, Y
    Ishigami, M
    Yano, M
    Watanabe, K
    Kobayashi, M
    Utsunomiya, S
    Kakumu, S
    HEPATOLOGY, 1997, 26 (04) : 690 - 690
12345